EU regulator advises caution on painkiller diclofenac

LONDON (Reuters) – Europe’s drugs agency warned on Friday that use of the common painkiller diclofenac, especially in high doses, carries extra heart attack risks which should be taken into consideration by doctors prescribing the drug. While it said the benefits of diclofenac, which is produced by several companies, still outweighed the risks, the European Medicines Agency recommended that precautions should be taken in certain patients. …